Author response for 'The benefit of dexamethasone in patients with COVID‐19 infection is preserved in patients with diabetes'

MLA

null Pei Chia Eng, et al. Author Response for “The Benefit of Dexamethasone in Patients with COVID‐19 Infection Is Preserved in Patients with Diabetes.” Mar. 2022. EBSCOhost, https://doi.org/10.1111/dom.14692/v2/response1.

APA

null Pei Chia Eng, null Walter Distaso, null Hashmi Durreshahwar, null Yusuf Shaikhali, null Divani Narendranathan, null Rebecca Cassin‐Scott, null Shivani Misra, null Neil E Hill, null George Tharakan, null Nick S. Oliver, null Tricia M Tan, null Chioma Izzi‐Engbeaya, & null Victoria Salem. (2022). Author response for “The benefit of dexamethasone in patients with COVID‐19 infection is preserved in patients with diabetes.” https://doi.org/10.1111/dom.14692/v2/response1

Chicago

null Pei Chia Eng, null Walter Distaso, null Hashmi Durreshahwar, null Yusuf Shaikhali, null Divani Narendranathan, null Rebecca Cassin‐Scott, null Shivani Misra, et al. 2022. “Author Response for ‘The Benefit of Dexamethasone in Patients with COVID‐19 Infection Is Preserved in Patients with Diabetes,’” March. doi:10.1111/dom.14692/v2/response1.